[HTML][HTML] Clinical practice guideline for the therapeutic drug monitoring of voriconazole in non-Asian and Asian adult patients: consensus review by the Japanese …

Y Takesue, Y Hanai, K Oda, Y Hamada, T Ueda… - Clinical Therapeutics, 2022 - Elsevier
Purpose Voriconazole, an antifungal drug, is metabolized by a cytochrome P450 isozyme.
Increased adverse effects are observed in Asians because of the high rate of poor …

Assessment of greenness for the determination of voriconazole in reported analytical methods

HK Chanduluru, A Sugumaran - RSC advances, 2022 - pubs.rsc.org
Analytical research with adverse environmental impact has caused a severe rise in concern
about the ecological consequences of its strategies, most notably the use and emission of …

Coronavirus disease 2019 in immunocompromised patients: a comprehensive review of coronavirus disease 2019 in hematopoietic stem cell recipients

A Lafarge, A Mabrouki, E Yvin, S Bredin… - Current Opinion in …, 2022 - journals.lww.com
Further studies are warranted to determine the proper impact of HSCT-related immune
disorders on COVID-19 outcomes, and to evaluate specific treatments and vaccination …

Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

LR Baden, S Swaminathan, NG Almyroudis… - Journal of the National …, 2024 - jnccn.org
There is an increased risk of infection in patients with cancer that results in higher morbidity
and mortality. Several risk factors can predispose these patients to infectious complications …

Co-administration with voriconazole doubles the exposure of ruxolitinib in patients with hematological malignancies

Y Zhao, P Chen, L Dou, F Li, M Li, L Xu… - Drug Design …, 2023 - Taylor & Francis
Background Ruxolitinib is newly approved for glucocorticoid-refractory acute graft-versus-
host disease (GVHD) in patients undergoing allo-geneic hematopoietic stem-cell …

External evaluation of published population pharmacokinetic models of posaconazole

S Huang, Q Ding, N Yang, Z Sun, Q Cheng… - Frontiers in …, 2022 - frontiersin.org
Population pharmacokinetic (PopPK) models of posaconazole have been established to
promote the precision dosing. However, the performance of these models extrapolated to …

Fungemia due to rare non-Candida yeasts between 2018 and 2021 in a Greek tertiary care university hospital

A Spiliopoulou, A Lekkou, G Vrioni, L Leonidou… - Journal of Medical …, 2023 - Elsevier
Abstract Introduction Non-Candida yeasts, although rare, are increasingly encountered and
recognized as a growing threat. Methods Cases of bloodstream infections (BSIs) due to non …

Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections

P Panagopoulou, E Roilides - Expert Opinion on Pharmacotherapy, 2022 - Taylor & Francis
ABSTRACT Introduction Invasive fungal diseases (IFDs) are a significant cause of morbidity
and mortality among immunocompromised patients. Safe and effective antifungal …

Effects of traditional Chinese exercise on vascular function in patients with Alzheimer's disease: a protocol for systematic review and network meta-analysis of …

J Li, C Wang, P Zhang - Medicine, 2023 - journals.lww.com
Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder with an
insidious onset, usually characterized by memory impairment, visual-spatial skill impairment …

Addition of ruxolitinib to standard graft-versus-host disease prophylaxis for allogeneic stem cell transplantation in aplastic anemia patients

X Zhang, X Zhao, S Chen, M Hao, L Zhang… - Bone Marrow …, 2024 - nature.com
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) offers rapid hematopoietic
and immune reconstitution for aplastic anemia (AA). As a non-malignant disorder …